SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-018025
Filing Date
2021-04-07
Accepted
2021-04-07 16:26:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rlay-defa14a_20210519.htm DEFA14A 31544
2 GRAPHIC ghne2y5tcciv000002.jpg GRAPHIC 36539
3 GRAPHIC ghne2y5tcciv000001.jpg GRAPHIC 126286
  Complete submission text file 0001564590-21-018025.txt   257034
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39385 | Film No.: 21812416
SIC: 2836 Biological Products, (No Diagnostic Substances)